Inhibition and deficiency of the immunoproteasome subunit LMP7 suppress the development and progression of colorectal carcinoma in mice

New treatment options and drug targets for colorectal carcinoma are a pressing medical need. Inflammation and pro-inflammatory cytokines produced by Th1 and Th17 cells like IL-6, TNF, IL-17 and IL-23 promote the development and growth of colorectal cancer (CRC). The immunoproteasome is a proteasome...

Descripción completa

Detalles Bibliográficos
Autores principales: Koerner, Julia, Brunner, Thomas, Groettrup, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584212/
https://www.ncbi.nlm.nih.gov/pubmed/28881611
http://dx.doi.org/10.18632/oncotarget.15141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584212/
https://www.ncbi.nlm.nih.gov/pubmed/28881611
http://dx.doi.org/10.18632/oncotarget.15141

Ejemplares similares